Want to see NXTC full AI Analyst Report?
Total Valuation
NextCure has a market cap or net worth of $6.79M. The enterprise value is -$4.35M.
Market Cap$6.79M
Enterprise Value-$4.35M
Share Statistics
NextCure has 3,612,096 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,612,096
Owned by Insiders―
Owned by Institutions48.82%
Financial Efficiency
NextCure’s return on equity (ROE) is -1.60 and return on invested capital (ROIC) is -141.83%.
Return on Equity (ROE)-1.60
Return on Assets (ROA)-1.11
Return on Invested Capital (ROIC)-141.83%
Return on Capital Employed (ROCE)-1.45
Revenue Per Employee0.00
Profits Per Employee-1.30M
Employee Count43
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of NextCure is ―. NextCure’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.00
PB Ratio1.15
Price to Fair Value1.15
Price to FCF-0.81
Price to Operating Cash Flow-0.20
PEG Ratio0.04
Income Statement
In the last 12 months, NextCure had revenue of 0.00 and earned -55.84M in profits. Earnings per share was -19.65.
Revenue0.00
Gross Profit-2.19M
Operating Income-57.62M
Pretax Income-55.84M
Net Income-55.84M
EBITDA-53.66M
Earnings Per Share (EPS)-19.65
Cash Flow
In the last 12 months, operating cash flow was -49.98M and capital expenditures 0.00, giving a free cash flow of -49.98M billion.
Operating Cash Flow-49.98M
Free Cash Flow-49.98M
Free Cash Flow per Share-13.84
Dividends & Yields
NextCure pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.34
52-Week Price Change-64.46%
50-Day Moving Average6.06
200-Day Moving Average9.66
Relative Strength Index (RSI)28.84
Average Volume (3m)37.58K
Important Dates
NextCure upcoming earnings date is Jul 30, 2026, TBA (Confirmed).
Last Earnings DateApr 30, 2026
Next Earnings DateJul 30, 2026
Ex-Dividend Date―
Financial Position
NextCure as a current ratio of 4.14, with Debt / Equity ratio of 18.43%
Current Ratio4.14
Quick Ratio4.14
Debt to Market Cap0.10
Net Debt to EBITDA0.39
Interest Coverage Ratio0.00
Taxes
In the past 12 months, NextCure has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
NextCure EV to EBITDA ratio is -0.36, with an EV/FCF ratio of -0.39.
EV to Sales0.00
EV to EBITDA-0.36
EV to Free Cash Flow-0.39
EV to Operating Cash Flow-0.39
Balance Sheet
NextCure has $29.74M in cash and marketable securities with $4.92M in debt, giving a net cash position of $24.82M billion.
Cash & Marketable Securities$29.74M
Total Debt$4.92M
Net Cash$24.82M
Net Cash Per Share$6.87
Tangible Book Value Per Share$12.29
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for NextCure is $20.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$20.00
Price Target Upside45.67% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast10.17%